340B Sales Totaled $7.5 Billion in 2013, Apexus Says

by Admin | February 14, 2014 9:07 am

February 14, 2014—Pharmaceutical purchases through the 340B discount program were an estimated $7.5 billion in 2013, the 340B Prime Vendor Program (PVP) reports.

Overall U.S. spending on pharmaceutical products in 2012, the most recent year for which data are available, stood at $326 billion, according to IMS Health Informatics Institute. Together, that figure and the new PVP data for 2013 suggest that 340B sales are in the neighborhood of 2.3 percent of the U.S. prescription drug market.

In a recent court filing, the Department of Health and Human Services said 340B sales totaled $6.9 billion in fiscal year 2012.

Apexus President Chris Hatwig provided the updated 340B sales figure last week during the 340B Coalition winter meeting in San Diego. Apexus operates PVP under a federal contract.

Hatwig also provided the following 340B statistics:

Source URL: https://340binformed.org/2014/02/340b-sales-totaled-7-5-billion-in-2013-apexus-says/